Europe’s pharmaceutical watchdog announced on Thursday that it had launched a database to inform the public and health professionals of suspected side effects in medicines. The online library, on http://www.adrreports.eu/, so far contains information relating to around 650 drugs, the London-based European Medicines Agency (EMA) said. “Today’s launch... highlights the importance of side-effects reporting and pharmacovigilance in safeguarding public health within the European Union,” it said. The reports come directly from the European Union’s medicines safety database, called EudraVigilance. The information comes from reports of adverse reactions submitted by patients and doctors to national regulatory authorities, as well as by pharmaceutical companies, which are legally required to do this to gain a licence to sell a drug in the EU. EMA stressed that the data relate to suspected side effects. “Suspected side effects may not be related to or caused by the medicine, and as a result, the published information cannot be used to determine the likelihood of experiencing a side effect or as an indication that a medicine is harmful,” it cautioned. The reports are being published first in English but should be rolled out in the EU’s 22 other official languages in the coming weeks.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor